“Venom: The Last Dance” is two-stepping slower than its series predecessors in North America, after chowing down on $22 million from 4,131 domestic theaters across Friday and previews. That’s well below the first-day debuts of both the first “Venom” in 2018 ($32 million) and its 2021 sequel “Let There Be Carnage” ($37 million).